Erb N - Search Results

1

High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood.

Erb N, Haverland U, Harms DO, Escherich G, Janka-Schaub G. Erb N, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 25;796(1):87-94. doi: 10.1016/j.jchromb.2003.08.006. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 14552819 Clinical Trial.

2

Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes.

Khalil MN, Erb N, Khalil PN, Escherich G, Janka-Schaub GE. Khalil MN, et al. Among authors: erb n. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):105-11. doi: 10.1016/j.jchromb.2005.04.028. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15897017

3

Validation and application of a high-performance liquid chromatographic-based assay for determination of the inosine 5'-monophosphate dehydrogenase activity in erythrocytes.

Khalil PN, Erb N, Khalil MN, Escherich G, Janka-Schaub GE. Khalil PN, et al. Among authors: erb n. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Sep 14;842(1):1-7. doi: 10.1016/j.jchromb.2006.04.040. Epub 2006 May 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2006. Retraction in: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):179. PMID: 16725387 Retracted.

4

Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.

Erb N, Harms DO, Janka-Schaub G. Erb N, et al. Cancer Chemother Pharmacol. 1998;42(4):266-72. doi: 10.1007/s002800050816. Cancer Chemother Pharmacol. 1998. PMID: 9744770 Clinical Trial.

5

RETRACTED: Modified high-performance liquid chromatographic conditions for determination of inosine 5'-monophosphate dehydrogenase activity inerythrocytes.

Khalil PN, Erb N, Khalil MN, Escherich G, Janka-Schaub GE. Khalil PN, et al. Among authors: erb n. J Pharmacol Toxicol Methods. 2006 Dec 20. doi: 10.1016/j.vascn.2006.12.001. Online ahead of print. J Pharmacol Toxicol Methods. 2006. PMID: 17346994

6

Pharmacokinetics of doxorubicin in man: dose and schedule dependence.

Erttmann R, Erb N, Steinhoff A, Landbeck G. Erttmann R, et al. Among authors: erb n. J Cancer Res Clin Oncol. 1988;114(5):509-13. doi: 10.1007/BF00391502. J Cancer Res Clin Oncol. 1988. PMID: 3182911

7

[Antineoplastic effectiveness and toxicity of idarubicin (4-demethoxy-daunorubicin) in recurrent acute leukemias in childhood].

Erttmann R, Bode U, Erb N, Forcadell de Dios P, Gutjahr P, Haas R, Kuhn N, Siewert H, Landbeck G. Erttmann R, et al. Among authors: erb n. Klin Padiatr. 1988 May-Jun;200(3):200-4. doi: 10.1055/s-2008-1033709. Klin Padiatr. 1988. PMID: 3062256 Clinical Trial. German.

8

[The pharmacokinetics of doxorubicin].

Erttmann R, Grandt M, Erb N, Garbrecht M, Landbeck G. Erttmann R, et al. Among authors: erb n. Klin Padiatr. 1986 May-Jun;198(3):271-6. doi: 10.1055/s-2008-1026889. Klin Padiatr. 1986. PMID: 3723990 Clinical Trial. German.

9

[Anthracycline transport in sensitive and resistant leukemia cells].

Erttmann R, Erb N, Forcadell de Dios P, Neurath C, Looft G, Landbeck G. Erttmann R, et al. Among authors: erb n. Klin Padiatr. 1989 Jan-Feb;201(1):40-5. doi: 10.1055/s-2007-1025273. Klin Padiatr. 1989. PMID: 2704176 German.

10

A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.

Erb N, Erttmann R, Landbeck G. Erb N, et al. Cancer Chemother Pharmacol. 1986;17(1):53-5. doi: 10.1007/BF00299866. Cancer Chemother Pharmacol. 1986. PMID: 3698178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters